Henry Schein, Inc.

$19.00

SKU: HSIC-1 Category:

Description

In the third quarter, Henry Schein reported mediocre financial performance with below-par revenues and earnings that were just about in line with analyst expectations. Despite decreased PPE and COVID-19 test sales, the company achieved commendable total sales and non-GAAP diluted EPS growth. As Henry Schein progresses through its BOLD+1 Strategic Plan, the management remains confident in the stability of dental and medical markets, adhering to strategic priorities despite cybersecurity incidents. Strategic investments and the recent acquisition of Shield Healthcare reinforce the company’s commitment to growth. The dental distribution segment experienced a temporary slowdown in patient traffic in September. However, consumable merchandise sales reflected this trend. In the international dental business, consumable merchandise volumes remained steady, and traditional dental equipment sales in North America returned to pre-pandemic levels. Dental equipment sales are expected to normalize in the first quarter of 2024. The dental specialties, including the global implant business, demonstrate growth, particularly through acquisitions. Despite some market challenges in North America, the endodontic and orthodontic segments are robust. The technology and value-added services businesses experienced excellent growth, driven by sales of practice management software and the acquisition of Large Practice Sales. In the medical business, growth remained in the low single digits.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!